Meet with BIOVECTRA at Phacilitate's Advanced Therapies Week 2024!
Miami Beach Convention Center | January 16 - 19, 2024
BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates. Schedule a meeting with us to discover how BIOVECTRA can help with your mRNA manufacturing needs.
Our state-of-the-art Biomanufacturing and Vaccine Center has the:
- Capability to develop and manufacture plasmid DNA, mRNA, and LNP formulations
- Ability to produce up to 160 million doses of mRNA vaccines per year
- Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution
At BIOVECTRA, we specialize in:
- Custom lipids
- pDNA/mRNA/LNP
- Biologics
- Synthetic small molecules
- Highly potent APIs
- Bioreagents
- Fill/Finish
Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.
|
Schedule a meeting with us and discover how we can support your
projects and solve your most complex challenges.
|
